Literature DB >> 3290703

Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case.

D J Marzewski1, J Towfighi, M G Harrington, C R Merril, P Brown.   

Abstract

A fourth histologically-confirmed American case of Creutzfeldt-Jakob disease (CJD) related to human growth hormone (hGH) therapy is reported. Like kuru, the illness was dominated by cerebellar signs and relatively little mental deterioration. The diagnosis was strongly supported premortem by the presence of two abnormal 30 kDa proteins in the CSF that are seen almost exclusively in CJD. The characteristic clinical picture coupled with such biochemical data allow a reasonably accurate premortem diagnosis of hGH-related iatrogenic CJD to be made.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290703     DOI: 10.1212/wnl.38.7.1131

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Pituitary growth hormone and Creutzfeldt-Jakob disease.

Authors:  M E Macario; M Vaisman; A Buescu; V Moura Neto; H M Araujo; C Chagas
Journal:  BMJ       Date:  1991-05-11

Review 2.  Etiology and pathogenesis of prion diseases.

Authors:  S J DeArmond; S B Prusiner
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

3.  Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment.

Authors:  R J Cordery; M Hall; L Cipolotti; S Al-Sarraj; D G O'Donovan; L Davidson; P Adlard; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.